← Back
$LXEO All transactions

Lexeo Therapeutics, Inc.

A

$ Value

$0

Shares

65,000

Price

$0

Filed

Feb 6

Insider

Name

Otero Jose Manuel

Title

Chief Operating Officer

CIK

0002024096

Roles

Officer

Transaction Details

Transaction Date

2026-02-04

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

128,476

Footnotes

The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2027, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date. | Includes 112,733 RSUs. | 25% of the shares underlying the option vest and become exercisable on February 4, 2027, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

Filing Info

Accession No.

0002024096-26-000002

Form Type

4

Issuer CIK

0001907108

Otero Jose Manuel's History

Date Ticker Type Value
2026-02-18 LXEO $19K
2026-02-04 LXEO A $0
2026-02-04 LXEO A $0
2025-11-18 LXEO $7K
2025-10-17 LXEO $19K
2025-10-17 LXEO $229
2025-10-15 LXEO A $0
2025-08-18 LXEO $13K
2025-08-18 LXEO $7K

Other Insiders at LXEO (90d)

Insider Bought Sold Last
Townsend Richard Nolan
Chief Executive Officer
$378K 2026-04-06
Otero Jose Manuel
Chief Operating Officer
$26K 2026-02-18
Tamayo Louis Edward
Chief Financial Officer
2026-02-04
Bhalla Narinder Pal
Chief Medical Officer
2026-02-13